Pityriasis rubra pilaris successfully treated with infliximab

Acta Dermato-Venereologica

Volumn 87, Issue 6, 2007, Pages 552-553

  Ruiz Genao, Diana P ^a   Lopez Estebaranz, Jose Luis ^a   Naz Villalba, Elena ^a   Gamo Villegas, Reyes ^a   Calzado Villarreal, Leticia ^a   Pinedo Moraleda, Fernando ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMITRIPTYLINE; CYCLOSPORIN; ETRETIN; FENOFIBRATE; INFLIXIMAB; IRBESARTAN; METFORMIN; TOPICAL AGENT; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANAMNESIS; ANXIETY DISORDER; CASE REPORT; DERMATITIS; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; ERYTHEMA; ERYTHRODERMA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERURICEMIA; LETTER; MONOTHERAPY; PALMOPLANTAR KERATODERMA; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; PRURITUS; SKIN BIOPSY; TOPICAL TREATMENT; DRUG ANTAGONISM; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; SKIN;

ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PITYRIASIS RUBRA PILARIS; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38849097228     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0308     Document Type: Letter

References (10)

1. Griffiths WAD. Pityriasis rubra pilaris. Clin Exp Dermatol 1980; 5: 105-112.
2. Miralies ES, Nunez M, De Las Heras ME, Perez B, Moreno R, Ledo A. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol 1995; 133: 990-993.
3. Cohen PR, Prystowsky JH. Pityriasis rubra pilaris: a review of diagnosis and treatment. J Am Acad Dermatol 1989; 20: 801-807.
4. Fox BJ, Odom RB. Papulosquamous diseases: a review. J Am Acad Dermatol 1985; 12: 597-624.
5. Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlie AB. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 2001; 357: 1842-1847.
6. Alexis A, Strober BE. Off-label dermatologie uses of anti-TNF-α therapies. J Cutan Med Surg 2005; 9: 296-302.
7. Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA. Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 2003; 7: 382-386.
8. Conaghan PG, Sommer S, McGonagle D, Veale D, Waldmann H, Hale G, et al. The relationship between pityriasis rubra pilaris and inflammatory arthritis. Arthritis Rheum 1999; 42: 1998-2001.
9. Liao WC, Mutasim DF. Infliximab for the treatment of adult-onset pityriasis rubra pilaris. Arch Dermatol 2005; 141: 423-425.
10. Manoharan S, White S, Gumparthy K. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab. Australas J Dermatol 2006; 47: 124-129.